Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

UK regulator approves antibody drug which may help tackle Omicron

December 2, 2021 Research and Development

UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …
News

EU bring forward launch of COVID-19 vaccine for children

December 1, 2021 Research and Development

The rollout of Pfizer and BioNTech’s COVID-19 vaccine version for children aged five to 11 years old will begin on …
News

UK Health Secretary Javid urges for more COVID-19 tests amid rising Omicron cases and vaccine developments

December 1, 2021 Research and Development

Health secretary of the UK, Sajid Javid, has urged the public to take lateral flow tests before attending parties this …
News

FDA approve first therapy to treat ultra-rare cancer

November 24, 2021 Research and Development

Aadi Bioscience announced that the FDA have approved the intravenous drug Fyarro (sirolimus protein-bound particles for injectable suspension) for the …
News

Ocuphire announces beginning of Phase III trial of treatment for reversal of mydriasis (RM)

November 24, 2021 Research and Development

Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company, announced that the first subjects have been enrolled in the MIRA-3 Phase III …
News

FDA approves Livtencity as first treatment for drug-resistant post-transplant infection

November 24, 2021 Manufacturing and Production, Research and Development

The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …
News

HUTCHMED and AstraZeneca begin Phase III trial of lung cancer treatment

November 24, 2021 Research and Development

HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …
News

NICE recommends Opdivo (nivolumab) for oesophageal cancer treatment

November 17, 2021 Research and Development

NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults who …
News

Health experts warn of a ‘hidden pandemic’ of antibiotic-resistant infections

November 17, 2021 Research and Development

UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight …
News

Pfizer deal allows generic versions of COVID pill for low-income countries

November 17, 2021 Research and Development

Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in …
News

US secures over 750,000 doses of GSK-Vir COVID-19 drug

November 17, 2021 Research and Development

The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …
News

Pfizer ask FDA to authorise COVID booster in adults

November 10, 2021 Research and Development

Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …
News

COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression

November 10, 2021 Research and Development

COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …
News

Pleco Therapeutics partners with Hyloris to develop novel cancer agent

November 10, 2021 Research and Development

Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025